0001209191-15-034045.txt : 20150414 0001209191-15-034045.hdr.sgml : 20150414 20150414171232 ACCESSION NUMBER: 0001209191-15-034045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150413 FILED AS OF DATE: 20150414 DATE AS OF CHANGE: 20150414 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Regulus Therapeutics Inc. CENTRAL INDEX KEY: 0001505512 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264738379 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-202-6300 MAIL ADDRESS: STREET 1: 3545 JOHN HOPKINS COURT STREET 2: SUITE 210 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARTER BRUCE L A CENTRAL INDEX KEY: 0001225503 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35670 FILM NUMBER: 15769904 MAIL ADDRESS: STREET 1: C/O ZYMOGENETICS, INC. STREET 2: 1201 EASTLAKE AVENUE CITY: SEATTLE STATE: WA ZIP: 98102 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-04-13 0 0001505512 Regulus Therapeutics Inc. RGLS 0001225503 CARTER BRUCE L A C/O REGULUS THERAPEUTICS INC. 3545 JOHN HOPKINS CT. #210 SAN DIEGO CA 92121 1 0 0 0 Common Stock 2015-04-13 4 M 0 20000 4.78 A 20000 D Common Stock 2015-04-13 4 S 0 20000 17.6582 D 0 D Stock Option (Right to Buy) 4.78 2015-04-13 4 M 0 20000 0.00 D 2022-10-30 Common Stock 20000 10000 D The weighted average sale price for the transaction reported was $17.6582, and the range of prices were between $17.65 and $17.685. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided. 25% of the shares will vest on October 31, 2013 and the remainder of the shares will vest in equal installments on a monthly basis thereafter, such that the option is fully vested on October 30, 2016. Christopher Aker, Attorney in Fact 2015-04-14